Pfizer and new partner BioNTech nab approval to start closely watched COVID-19 vax trial

Pfizer has been granted approval in partner BioNTech’s native country Germany to kick-start a phase 2 test of their experimental mRNA vaccine for COVID-19.

Pfizer and new partner BioNTech nab approval to start closely watched COVID-19 vax trial
Pfizer has been granted approval in partner BioNTech’s native country Germany to kick-start a phase 2 test of their experimental mRNA vaccine for COVID-19.